Novo Nordisk Pharmatech

Insulin Human for Cell Culture Media and cGMP-Manufactured Quaternary Ammonium Compounds

Københavnsvej 216, DK - 4600 Køge, Denmark



Ingredients for pharmaceutical industry

Novo Nordisk Pharmatech is a Novo Nordisk company specialising in the supply of ingredients for the biopharmaceutical and pharmaceutical industries, such as human insulin for cell culture media and current good manufacturing practices (cGMP) manufactured quaternary ammonium compounds (usually referred to as quats), including benzalkonium chloride, cetrimide, and cetrimonium bromide.

Novo Nordisk Pharmatech’s insulin products include:

  • Insulin from the largest manufacturer worldwide
  • European Pharmacopoeia (Ph Eur) and United States Pharmacopeia (USP) compliance
  • Comprehensive documentation
  • Full traceability
  • Supply guarantee
  • Flexibility

cGMP-manufactured quats offered include:

  • Global regulatory compliance
  • Manufacture in accordance with the highest good manufacturing practice (GMP) standards on the market, the ICH Guide Q7 for active pharmaceutical ingredients (API)
  • High-purity products
  • Analysis according to multicompendial pharmacopoeias: British Pharmacopoeia (BP), Ph Eur, United States Pharmacopeia and National Formulary (USP-NF) and Japanese Pharmacopoeia (JP)
  • Regulatory documentation

As an approved supplier by a large number of global leading pharmaceutical companies, Novo Nordisk Pharmatech can assure full traceability and reliability of raw materials. The company has a well-developed management system, allowing traceing of where raw materials are used. Novo Nordisk Pharmatech also has close contact with suppliers and can meet customer-requested specifications.

Quality assurance and cGMP compliance

Consciousness in quality is an integrated part of Novo Nordisk Pharmatech’s work, enabling the company to offer outstanding products and services. By regular internal and external staff training and education, it always follows the latest guideline requirements.

Novo Nordisk Pharmatech’s quality system meets DS/EN ISO 9001 and ICH’s cGMP guide for API (ICH Q7). Uniform quality of finished products is ensured by the firm’s efficient quality control systems, computerised materials planning, and rigorous laboratory quality control. In-process samples and finished products are carefully analysed in a modern, well-equipped laboratory.

Customised pharmaceutical products

Novo Nordisk Pharmatech is supporting innovation by offering customised solutions to meet specific requirements.

Fast and reliable services in documentation, analyses, and manufacturing, fulfilling local and international regulatory requirements are key to securing customer satisfaction.

Novo Nordisk Pharmatech’s delivery and stock policy for pharmaceutical products is determined to meet the most demanding and urgent requirements and pharmaceutical products can be shipped within a week. The company’s range of products is also offered in a variety of packing solutions, meeting demands for small and large packaging.

Environmental responsibility

As a chemical manufacturer, Novo Norisk Pharmatech’s considerations for the surrounding environment takes a very high priority.

The company continuously focus on improving its environmental efforts and it has implemented a management system according to DS/EN ISO 14001. Novo Nordisk Pharmatech also acts in accordance with environmental legislation and other declarations of intent.

Novo Nordisk Pharmatech continuously aims to reduce its environmental impact by optimising effective resource utilisation and minimising discharge and waste. As a Novo Nordisk company, Novo Nordisk Pharmatech works with the Triple Bottom Line concept, conducting activities in a financially, environmentally, and socially responsible way.

Quaternary ammonium compounds (quats) for the pharmaceutical industry

Novo Nordisk Pharmatech focuses on manufacturing quaternary ammonium compounds for the pharmaceutical and personal care industries. Its own innovative synthesis process makes the company a leading supplier of crystalline quats. This ensures a very high level of purity of our crystalline products such as cetrimide, cetrimonium bromide (CTAB) and myristalkonium chloride (MKC).

By using raw materials of high purity and following its stringent quality system, Novo Nodisk pharmatech’s products are particularly suited for applications within the pharmaceutical industry. They act as preservatives in many ophthalmic, nasal, and oral drugs, as well as for active ingredients in a variety of topical and antiseptic solutions, ointments and creams. For the cosmetic industry, our quats’ purity and characteristics provide ideal conditioning, emulsifying and preserving effects in hair and cream products.

Thanks to Novo Nordisk Pharmatech’s closely-controlled production process, reducing batch variation to a minimum, the company is highly valued by diagnostic reagent sector. Combined with their high purity, this makes our quats significantly superior to other less pure compounds.

Customised quats

If the required product is not in the standard assortment, we can design customised products. Our flexible production process can meet customer demands for special chain length distribution and / or solutions of quats mixed in various ratios.

Regulatory documentation for pharmaceutical compliance

As a supplier to the pharmaceutical, personal care and cosmetic industries, Novo Nordisk Pharmatech emphasises on the importance of offering quality products with the appropriate and necessary documentation. The company is fully aware of the importance of the drug registration phase within the pharmaceutical industry.

Novo Nordisk Pharmatech offers an extensive range of documentation on its pharmaceutical grade products, such as multicompendial analysis and access to regulatory documentation.

Through highly qualified support, the firm ensures the best possible service and fast preparation of documentation, such as drug master files for its pharmaceutical-grade products. To further facilitate the drug registration process, Novo Nordisk Pharmatech offers access to its certificates of suitability according to the monographs of the Ph Eur, for benzalkonium chloride solution 50% and benzalkonium.

FeF® Benzalkonium Chloride Solution 17% USP/NF (BKC/BAC/BAK)

CAS No. 8001-54-5. Custom design solution consisting of Benzyl (dodecyl) dimethyl ammonium chloride (approximately 65%) and Benzyl (tetradecyl) dimethyl ammonium chloride (approximately 35%). Contains approximately 17% active ingredients.

FeF® Benzalkonium Chloride (3% C16) USP/NF (BKC/BAC/BAK)

CAS No. 8001-54-5. Custom design product consisting of Benzyl (dodecyl) dimethyl ammonium chloride (approximately 64%), Benzyl (tetradecyl) dimethyl ammonium chloride (approximately 34%) and Benzyl (hexadecyl) dimethyl ammonium chloride (approximately 2%-3%). Contains approximately 95% active ingredients.

FeF® Cetrimide Ph.Eur

Other names: Cetrimoni bromidum / Tetradecyl trimethyl ammonium bromide (TTAB) / Myristyl trimethyl ammonium bromide (MTAB) / Mytrimonium bromide.

FeF® CTAB USP/NF

CTAB or Cetrimonium bromide (CAS No. 57-09-0) can be used for several purposes in the pharmaceutical industry.

FeF® Strong Cetrimide Solution 40% BP Pharma with Ethanol

Also known as Cetrimide, Cetrimoni Bromidum and Tetradecyl Trimethyl Ammonium Bromide (TTAB), FeF® Strong Cetrimide Solution 40% BP Pharma with Ethanol FeF® (CAS No. 1119-97-7) consists of approximately 20% dodecyl trimethyl ammonium bromide, approximately 70% trimethyl tetradecyl ammonium bromide and around 10% hexadecyl trimethyl ammonium bromide.

FeF® Strong Cetrimide Solution 40% BP Pharma With Isopropyl Alcohol

Also known as Cetrimide, Cetrimoni Bromidum and Tetradecyl trimethyl ammonium bromide (TTAB), FeF® Strong Cetrimide Solution 40% BP Pharma with isopropyl alcohol (CAS No. 1119-97-7) consists of around 20% dodecyl trimethyl ammonium bromide and approcimately 80% trimethyl tetradecyl ammonium bromide, as well as approximately 7.5% volume by volume (v/v) isopropyl alcohol.

Recombinant Insulin Human

Novo Nordisk Pharmatech supplies recombinant insulin for cell culture processes by providing excellence at every step of the supply chain.

DKSH to Distribute Novo Nordisk’s High-Quality Quats

Novo Nordisk Pharmatech has entered a new era in supplying high-quality quarternary ammonium compounds (quats). DKSH will now be providing market expansion services (MES) for eleven markets in the Asia Pacific (APAC).

Ensuring Regulatory Compliance with Brenntag Specialities

Regulations are tightening, and supply chains are shifting, so we asked a Brenntag specialist with more than four decades of expertise in the industry how Brenntag and Novo Nordisk Pharmatech can assist the US pharma market currently and in future.

Novo Nordisk Opens New Branch in Singapore

Novo Nordisk Pharmatech A / S is pleased to announce the opening of a new branch in Singapore at 152 Beach Road #17-04 The Gateway East, which opened on September 2019.

Global Supply by Local Distribution

To provide the best possible customer service, Novo Nordisk Pharmaceuticals now offers distribution from two separate warehouse locations that serve a global client base. One is located in Plainfield, Indiana, US, and the other facility is located near Copenhagen, Denmark.

Novo Nordisk Pharmatech A/S